TCL Archive Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival October 25, 2013
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive NCI Provides $40 Million To Four Centers For Cancer Communications Research. June 27, 2003
TCL Archive Gio Gori And The “Tolerable” Smoking Flap; Controversy When He Needs It Least August 18, 1978